Evaluating the equilibrium between IFN-γ and anti-inflammatory cytokines (IL-4 + IL-10 + IL-13) revealed tumor progression is accompanied by an increased inflammatory balance in 4T1 tumors (P=0.0004), in contrast to MC4-L2 tumors (Figure 4C, D). This evidence concerns the gene IL13 and neoplasm.